Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

310 results found

2026 ∙ Hayford, K. Tort, M. J. Huang, L. Forbes, C. Pustulka, I. Chapman, R. Theilacker, C.

Clinical effectiveness and impact of 13-valent pneumococcal conjugate vaccines in preventing invasive pneumococcal disease among children with risk conditions: A systematic literature review

  • Newborn
  • Children
  • Adolescents
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2026 ∙ Gulati, R. R. Yaqub, F. Goodman, A. L.

Enhancing uptake of respiratory vaccinations in asthma and chronic obstructive pulmonary disease (COPD) patients: a systematic review

  • Adults
  • Influenza
  • COVID-19
  • Pneumococcal disease
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2026 ∙ Chen, X. Tavlian, S. Carville, K. S. Tellioglu, N. Spirkoska, V. Carvalho, N. Price, D. J. Campbell, P. T. McVernon, J.

Impact of CRM197-based conjugate vaccines, schedules, and regions on pneumococcal immunogenicity in young children: systematic review

  • Newborn
  • Children
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2026 ∙ Borlini, S. Pennisi, F. Pinto, A. De Ponti, E. D’Amelio, A. C. Signorelli, C.

Impact of pharmacy-based interventions on vaccination coverage among vulnerable and underserved populations: a systematic review and meta-analysis

  • Adults
  • Older adults
  • Pneumococcal disease
  • Influenza
  • Tetanus
  • Diphtheria
  • Pertussis
  • Hepatitis B
  • Herpes zoster
  • Hepatitis A
  • Haemophilus influenzae type B
  • Meningococcal disease
  • Measles
  • Mumps
  • Rubella
  • Human papillomavirus (HPV)
  • Coverage
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2026 ∙ Cireasa, B. Leguelinel-Blache, G. Occean, B. V. Serrand, C. Kinowski, J. M. Dubois, F.

Interventions to improve pneumococcal vaccination coverage: A systematic review and meta-analysis

  • All age groups
  • Pneumococcal disease
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2026 ∙ Han, L. Gao, C. Liu, J. Li, Y. Liu, M. Liu, H. Wu, J.

Pneumococcal vaccine for prevention of acute otitis media in children: a meta-analysis

  • Children
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Low
2026 ∙ Faijue, D. D. Bouaddi, O. Mackey, K. Deal, A. Cinar, E. N. Morais, B. Bojang, S. Al-Sharabi, I. Seale, H. Ssali, A. Le Doare, K. Hargreaves, S.

Strategies, interventions, and uptake of catch-up vaccination among adolescent and adult migrants, refugees, and internally displaced persons (IDPs) in low- and middle-income countries (LMICs): A systematic review

  • Adolescents
  • Adults
  • Low and Middle Income Countries
  • Measles
  • Rubella
  • COVID-19
  • Human papillomavirus (HPV)
  • Poliomyelitis
  • Hepatitis B
  • Tetanus
  • Pertussis
  • Diphtheria
  • Pneumococcal disease
  • Typhoid
  • Meningococcal disease
  • Coverage
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2026 ∙ Lertussavavivat, T. Isaranuwatchai, S. Eiam-Ong, S. Praditpornsilpa, K. Susantitaphong, P.

Vaccine efficacy in CKD patients not on dialysis: a systematic review and meta-analysis

  • Adults
  • Older adults
  • Hepatitis B
  • COVID-19
  • Influenza
  • Pneumococcal disease
  • Herpes zoster
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Low
2026 ∙ I-Fan Lin

Recommendations and guidance for pneumococcal vaccination for adults in Taiwan

  • Western Pacific
  • Pneumococcal disease
Download:
2026 ∙ Haute Autorité de Santé

Review of the vaccination strategy against invasive pneumococcal infections

  • Recommendation
  • Europe
  • France
  • NITAG recommendation
  • Pneumococcal disease
Download:
Loading...